Core One Labs Inc
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and op… Read more
Core One Labs Inc - Asset Resilience Ratio
Core One Labs Inc (CLABF) has an Asset Resilience Ratio of 1.49% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how Core One Labs Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Core One Labs Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $110.00K | 1.49% |
| Total Liquid Assets | $110.00K | 1.49% |
Asset Resilience Insights
- Limited Liquidity: Core One Labs Inc maintains only 1.49% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Core One Labs Inc Industry Peers by Asset Resilience Ratio
Compare Core One Labs Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Core One Labs Inc (2016–2023)
The table below shows the annual Asset Resilience Ratio data for Core One Labs Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-03-31 | 1.36% | $110.00K | $8.11 Million | -0.09pp |
| 2022-03-31 | 1.45% | $110.00K | $7.61 Million | -12.94pp |
| 2021-03-31 | 14.38% | $1.37 Million | $9.52 Million | +12.73pp |
| 2020-03-31 | 1.66% | $295.00K | $17.80 Million | -0.91pp |
| 2019-03-31 | 2.57% | $541.24K | $21.06 Million | -- |
| 2018-03-31 | 0.00% | $0.00 | $13.13 Million | -- |
| 2017-03-31 | 0.00% | $0.00 | $1.67 Million | -- |
| 2016-03-31 | 0.00% | $0.00 | $1.43 Million | -- |